POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV (BIT225-010)
Preliminary analyses indicate that the primary objectives of the trial have been met.
The results suggest that BIT225 is having a unique effect beyond that seen with current standard of
care antiretroviral drugs.
The data is consistent with BIT225 targeting virus present in reservoir cells.
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV, page-15
-
- There are more pages in this discussion • 283 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
